PEOPLE - Cambridge Heart makes appointment:
This article was originally published in Clinica
US cardiac diagnostics firm Cambridge Heart (Bedford, Massachusetts) has appointed Roderick de Greef as CFO. Formerly, Mr de Greef was executive vice-president, CFO and secretary for California-based cardiac defibrillator firm Cardiac Science. He also serves on the boards of: stent developer Endologix and dental device maker, Dental View.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.